In this week’s DeviceTalks Weekly podcast, we’ll first delve into Medtech’s own brewing Supreme Court battle.
J. Michael Jakes, a partner at Finnegan, will tell us why the industry should be watching when the Supremes review the latest patent battle between Arthrex and Smith+Nephew.
We’ll also talk about Medtronic’s Analyst Meeting where CEO Geoff Martha and the team rolled out its decentralization plan that calls for the creation of 20 semi-independent business units. Kaila Krum, managing director at Truist Securities, returns to break down the highlight of the meetings including pipelines and partnership with The Foundry, Amazon and others.
Sean Whooley, assistant editor at Mass Device, pinch hosts for the vacationing Chris Newmarker and delivers with a rock-solid #newmarkersnewsmakers that includes news from Abbott, Arthrex, Smith & Nephew, GE, and, of course, Medtronic.